Keyword search (4,163 papers available)

"Trial" Keyword-tagged Publications:

Title Authors PubMed ID
1 Resistance training and subcortical vascular cognitive impairment: A 12-month randomized trial Liu-Ambrose T; Falck RS; Dao E; Crockett RA; Barha CK; Silva NCBS; Alkeridy WA; Best JR; Hsiung GR; Field TS; Madden KM; Davis JC; Ten Brinke LF; Tam RC; 41795685
HKAP
2 Toward a Sustainable Future: A Holistic Environmental, Social, and Economic Assessment of Industrial Recycling for All-Solid-State Batteries with Oxide-Based Electrolytes Wang Z; Tian X; Zhao S; Zhang P; An C; 41073076
ENCS
3 Post-subsidy Era: Potential for Carbon Pricing in Industrial Fisheries among Global Major Fishing Countries Peng H; Hao J; Lyu L; Wan S; An C; 40737555
ENCS
4 Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Collins DL; Dadar M; DeMarco ML; Ducharme S; Duchesne S; Einstein G; Fisk JD; Gawryluk JR; Grossman L; Ismail Z; Itzhak I; Joshi M; Harrison A; Kroger E; Kumar S; Laforce R; Lanctot KL; Lau M; Lee L; Masellis M; Massoud F; Mitchell SB; Montero-Odasso M; Myers Barnett K; Nygaard HB; Pasternak SH; Peters J; Rajah MN; Robillard JM; Rockwood K; Rosa-Neto P; Seitz DP; Soucy JP; Trenaman SC; Wellington CL; Zadem A; Chertkow H; 39893139
CONCORDIA
5 The hockey fans in training intervention for men with overweight or obesity: a pragmatic cluster randomised trial Petrella RJ; Gill DP; Boa Sorte Silva NC; Riggin B; Blunt WM; Kfrerer M; Majoni M; Marsh J; Irwin JD; Stranges S; Zwarenstein M; Zou G; 39568632
HKAP
6 A protocol for trustworthy EEG decoding with neural networks Borra D; Magosso E; Ravanelli M; 39549492
ENCS
7 AAT4IRS: automated acceptance testing for industrial robotic systems Dos Santos MG; Hallé S; Petrillo F; Guéhéneuc YG; 39420929
ENCS
8 Investigating the kinetics of marine and terrestrial organic carbon incorporation and degradation in coastal bulk sediment and water settings through isotopic lenses Mirzaei Y; Gélinas Y; 39117203
CHEMBIOCHEM
9 A randomized controlled trial of an acceptance-based, insight-inducing medication adherence therapy (AIM-AT) for adults with early-stage psychosis Chien WT; Chong YY; Bressington D; McMaster CW; 38908265
CONCORDIA
10 How to present work productivity loss results from clinical trials for patients and caregivers? A mixed methods approach L' Heureux J; McTaggart-Cowan H; Johns G; Chen L; Steiner T; Tocher P; Sun H; Zhang W; 37276772
JMSB
11 Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease Nayak SS; Naidu A; Sudhakaran SL; Vino S; Selvaraj G; 37109050
CHEMBIOCHEM
12 A multi-center, randomized, 12-month, parallel-group, feasibility study to assess the acceptability and preliminary impact of family navigation plus usual care versus usual care on attrition in managing pediatric obesity: a study protocol Ball GDC; O' Neill MG; Noor R; Alberga A; Azar R; Buchholz A; Enright M; Geller J; Ho J; Holt NL; Lebel T; Rosychuk RJ; Tarride JE; Zenlea I; 36691103
HKAP
13 The effects of walking in nature on negative and positive affect in adult psychiatric outpatients with major depressive disorder: A randomized-controlled study Watkins-Martin K; Bolani D; Richard-Devantoy S; Pennestri MH; Malboeuf-Hurtubise C; Philippe F; Guindon J; Gouin JP; Ouellet-Morin I; Geoffroy MC; 36058362
PSYCHOLOGY
14 Neural evidence for age-related deficits in the representation of state spaces Ruel A; Bolenz F; Li SC; Fischer A; Eppinger B; 35510942
PERFORM
15 Recent developments in photocatalysis of industrial effluents ։ A review and example of phenolic compounds degradation Motamedi M; Yerushalmi L; Haghighat F; Chen Z; 35074327
ENCS
16 Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Thombs BD, Kwakkenbos L, Carrier ME, Bourgeault A, Tao L, Harb S, Gagarine M, Rice D, Bustamante L, Ellis K, Duchek D, Wu Y, Bhandari PM, Neupane D, Carboni-Jiménez A, Henry RS, Krishnan A, Sun Y, Levis B, He C, Turner KA, Benedetti A, Culos-Reed N, El-Baalbaki G, Hebblethwaite S, Bartlett SJ, Dyas L, Patten S, Varga J, Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory Team, SPIN Investigators 32521358
PSYCHOLOGY
17 Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Fortuné C, Gietzen A, Guillot G, Lewis N, Nielsen K, Richard M, Sauvé M, Welling J, SPIN Investigators, Baron M, Furst DE, Gottesman K, Malcarne V, Mayes MD, Mouthon L, Nielson WR, Riggs R, Wigley F, Assassi S, Boutron I, Ells C, van den Ende C, Fligelstone K, Frech T, Godard D, Harel D, Hinchcliff M, Hudson M, Johnson SR, Larche M, Leite C, Nguyen C, Pope J, Portales A, Rannou F, Reyna TSR, Schouffoer AA, Suarez-Almazor ME, Agard C, Albert A, André M, Arsenault G, Benzidia I, Bernstein EJ, Berthier S, Biss 32419703
PSYCHOLOGY
18 An international, Delphi consensus study to identify priorities for methodological research in behavioral trials in health research. Byrne M, McSharry J, Meade O, Lavoie KL, Bacon SL 32293510
HKAP
19 Group sample sizes in nonregulated health care intervention trials described as randomized controlled trials were overly similar Thombs BD; Levis AW; Azar M; Saadat N; Riehm KE; Sanchez TA; Chiovitti MJ; Rice DB; Levis B; Fedoruk C; Lyubenova A; Malo Vázquez de Lara AL; Kloda LA; Benedetti A; Shrier I; Platt RW; Kimmelman J; 31866472
LIBRARY
20 Reproducibility of EEG-MEG fusion source analysis of interictal spikes: Relevance in presurgical evaluation of epilepsy. Chowdhury RA, Pellegrino G, Aydin Ü, Lina JM, Dubeau F, Kobayashi E, Grova C 29164737
PERFORM

 

Title:Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.
Authors:Thombs BDKwakkenbos LCarrier MEBourgeault ATao LHarb SGagarine MRice DBustamante LEllis KDuchek DWu YBhandari PMNeupane DCarboni-Jiménez AHenry RSKrishnan ASun YLevis BHe CTurner KABenedetti ACulos-Reed NEl-Baalbaki GHebblethwaite SBartlett SJDyas LPatten SVarga JScleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory TeamSPIN Investigators
Link:https://www.ncbi.nlm.nih.gov/pubmed/32521358?dopt=Abstract
DOI:10.1016/j.jpsychores.2020.110132
Publication:Journal of psychosomatic research
Keywords:AnxietyCOVID-19CoronavirusMental healthRCTSclerodermaSystemic sclerosisTrial
PMID:32521358 Category:J Psychosom Res Date Added:2020-06-11
Dept Affiliation: PSYCHOLOGY
1 Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada; Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada. Electronic address: brett.thombs@mcgill.ca.
2 Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands.
3 Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
4 Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
5 Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
6 Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada.
7 Department of Applied Human Sciences, Concordia University, Montreal, Quebec, Canada.
8 Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.
9 Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Centre for Prognosis Research, School of Primary, Community and Social Care, Keele University, Staffordshire, UK.
10 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada.
11 Department of Applied Human Sciences, Concordia University, Montreal, Quebec, Canada; Department of Oncology, Cumming School of Medicine, Calgary, Canada; Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada.
12 Department of Psychology, Université du Québec à Montréal, Montreal, Quebec, Canada.
13 Department of Medicine, McGill University, Montreal, Quebec, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
14 Scleroderma Foundation Michigan Chapter, Southfield, MI, USA.
15 Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
16 Northwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
17 Ottawa Scleroderma Support Group, Ottawa, Ontario, Canada.
18 Scleroderma Foundation, Danvers, Massachusetts, USA.
19 Sclérodermie Québec, Longueuil, Quebec, Canada.
20 Toronto, Ontario, Canada.
21 Scleroderma Society of Ontario, Hamilton, Ontario, Canada.
22 Past-president of Scleroderma Canada, Halifax, Nova Scotia, Canada.
23 Scleroderma Society of Ontario and Scleroderma Canada, Hamilton, Ontario, Canada.
24 NVLE Du

Description:

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.

J Psychosom Res. 2020 May 14;135:110132

Authors: Thombs BD, Kwakkenbos L, Carrier ME, Bourgeault A, Tao L, Harb S, Gagarine M, Rice D, Bustamante L, Ellis K, Duchek D, Wu Y, Bhandari PM, Neupane D, Carboni-Jiménez A, Henry RS, Krishnan A, Sun Y, Levis B, He C, Turner KA, Benedetti A, Culos-Reed N, El-Baalbaki G, Hebblethwaite S, Bartlett SJ, Dyas L, Patten S, Varga J, Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory Team, SPIN Investigators

Abstract

OBJECTIVE: Contagious disease outbreaks and related restrictions can lead to negative psychological outcomes, particularly in vulnerable populations at risk due to pre-existing medical conditions. No randomised controlled trials (RCTs) have tested interventions to reduce mental health consequences of contagious disease outbreaks. The primary objective of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Trial is to evaluate the effect of a videoconference-based program on symptoms of anxiety. Secondary objectives include evaluating effects on symptoms of depression, stress, loneliness, boredom, physical activity, and social interaction.

METHODS: The SPIN-CHAT Trial is a pragmatic RCT that will be conducted using the SPIN-COVID-19 Cohort, a sub-cohort of the SPIN Cohort. Eligible participants will be SPIN-COVID-19 Cohort participants without a positive COVID-19 test, with at least mild anxiety (PROMIS Anxiety 4a v1.0 T-score?=?55), not working from home, and not receiving current counselling or psychotherapy. We will randomly assign 162 participants to intervention groups of 7 to 10 participants each or waitlist control. We will use a partially nested RCT design to reflect dependence between individuals in training groups but not in the waitlist control. The SPIN-CHAT Program includes activity engagement, education on strategies to support mental health, and mutual participant support. Intervention participants will receive the 4-week (3 sessions per week) SPIN-CHAT Program via videoconference. The primary outcome is PROMIS Anxiety 4a score immediately post-intervention.

ETHICS AND DISSEMINATION: The SPIN-CHAT Trial will test whether a brief videoconference-based intervention will improve mental health outcomes among at-risk individuals during contagious disease outbreak.

PMID: 32521358 [PubMed - as supplied by publisher]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University